| NCT03375320 |
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT03375320 |
Recruiting |
National Cancer Institute (NCI) |
2021-01-01 |
| NCT03350490 |
Bioinformation Therapy for Intestinal Cancer |
https://ClinicalTrials.gov/show/NCT03350490 |
Completed |
Fuda Cancer Hospital, Guangzhou |
2018-11-30 |
| NCT03280407 |
NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer |
https://ClinicalTrials.gov/show/NCT03280407 |
Recruiting |
Zealand University Hospital |
2018-12-31 |
| NCT03271255 |
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) |
https://ClinicalTrials.gov/show/NCT03271255 |
Recruiting |
Shenzhen People’s Hospital |
2022-09-30 |
| NCT03072472 |
BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities |
https://ClinicalTrials.gov/show/NCT03072472 |
Completed |
South Tyneside and Sunderland NHS Foundation Trust |
2018-02-13 |
| NCT03037385 |
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03037385 |
Recruiting |
Blueprint Medicines Corporation |
2021-12-31 |
| NCT02785783 |
Endoringsâ„¢ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection |
https://ClinicalTrials.gov/show/NCT02785783 |
Completed |
Portsmouth Hospitals NHS Trust |
2018-08-07 |
| NCT02585362 |
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program |
https://ClinicalTrials.gov/show/NCT02585362 |
Completed |
Kantonsspital Winterthur KSW |
2018-10-31 |
| NCT02038114 |
The Impact of a Patient Education Intervention for Ambulatory Oncology Patients |
https://ClinicalTrials.gov/show/NCT02038114 |
Completed |
Sunnybrook Health Sciences Centre |
2014-06-30 |
| NCT03043664 |
Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT03043664 |
Active, not recruiting |
Duke University |
2020-09-30 |
| NCT02489422 |
Programs To Support You During Chemotherapy |
https://ClinicalTrials.gov/show/NCT02489422 |
Completed |
Wake Forest University Health Sciences |
2020-01-31 |
| NCT02381561 |
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy |
https://ClinicalTrials.gov/show/NCT02381561 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-11-08 |
| NCT02200055 |
Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need |
https://ClinicalTrials.gov/show/NCT02200055 |
Completed |
United States Naval Medical Center, Portsmouth |
2015-07-31 |
| NCT02185443 |
Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases |
https://ClinicalTrials.gov/show/NCT02185443 |
Recruiting |
University of Sao Paulo |
2021-05-31 |
| NCT01273090 |
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT01273090 |
Completed |
Children’s Oncology Group |
2013-09-30 |
| NCT01996306 |
A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC |
https://ClinicalTrials.gov/show/NCT01996306 |
Completed |
Epidemiological and Clinical Research Information Network |
2017-11-20 |
| NCT01995084 |
In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study |
https://ClinicalTrials.gov/show/NCT01995084 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2014-06-30 |
| NCT01887158 |
Efficacy of 2-Liter Mixed Preparation With Bisacodyl Plus Polyethylene Glycol and 4-Liter Polyethylene Glycol for Colon Cleansing in Patients With Prior History of Colorectal Resection |
https://ClinicalTrials.gov/show/NCT01887158 |
Completed |
Ospedale Santa Maria delle Croci |
2014-06-30 |
| NCT01841736 |
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors |
https://ClinicalTrials.gov/show/NCT01841736 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-03-05 |
| NCT01747096 |
TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT01747096 |
Completed |
Nantes University Hospital |
2016-05-31 |
| NCT04267575 |
Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites |
https://ClinicalTrials.gov/show/NCT04267575 |
Recruiting |
Jerome Canady Research Institute for Advanced Biological & Technological Sciences |
2020-07-30 |
| NCT04080843 |
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients |
https://ClinicalTrials.gov/show/NCT04080843 |
Recruiting |
Zhejiang University |
2020-08-31 |
| NCT04077372 |
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers |
https://ClinicalTrials.gov/show/NCT04077372 |
Recruiting |
Stanford University |
2020-09-30 |
| NCT03915171 |
Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer |
https://ClinicalTrials.gov/show/NCT03915171 |
Recruiting |
China Medical University, China |
2019-12-01 |
| NCT03891784 |
Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT03891784 |
Recruiting |
University of Washington |
2023-09-30 |
| NCT03608540 |
Endomina as an Aid for Endoscopic Full Thickness Resection |
https://ClinicalTrials.gov/show/NCT03608540 |
Recruiting |
Erasme University Hospital |
2021-07-31 |
| NCT03576872 |
The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients |
https://ClinicalTrials.gov/show/NCT03576872 |
Completed |
Dana-Farber Cancer Institute |
2019-09-30 |
| NCT03559543 |
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT03559543 |
Recruiting |
Catalysis SL |
2020-11-30 |
| NCT01263353 |
Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs |
https://ClinicalTrials.gov/show/NCT01263353 |
Completed |
Novartis |
2014-03-31 |
| NCT01204476 |
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma |
https://ClinicalTrials.gov/show/NCT01204476 |
Completed |
National Cancer Institute (NCI) |
2014-07-31 |
| NCT01046864 |
Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) |
https://ClinicalTrials.gov/show/NCT01046864 |
Completed |
Bristol-Myers Squibb |
2014-06-30 |
| NCT01037049 |
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks |
https://ClinicalTrials.gov/show/NCT01037049 |
Active, not recruiting |
Royal Marsden NHS Foundation Trust |
2014-12-08 |
| NCT01016639 |
Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer |
https://ClinicalTrials.gov/show/NCT01016639 |
Completed |
Lund University Hospital |
2007-07-31 |
| NCT01010126 |
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer |
https://ClinicalTrials.gov/show/NCT01010126 |
Completed |
National Cancer Institute (NCI) |
2017-03-13 |
| NCT00994903 |
Simvastatin in Colorectal Surgery |
https://ClinicalTrials.gov/show/NCT00994903 |
Completed |
University of Auckland, New Zealand |
2013-09-30 |
| NCT00987766 |
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer |
https://ClinicalTrials.gov/show/NCT00987766 |
Completed |
Vanderbilt-Ingram Cancer Center |
2013-07-31 |
| NCT01563991 |
Impact of Perioperative Intravenous Fluid Utilization on Postoperative Outcomes |
https://ClinicalTrials.gov/show/NCT01563991 |
Completed |
The Cleveland Clinic |
2012-04-18 |
| NCT01910974 |
Multicentric Study an Endoscopic Treatment of Digestive Neoplasia by Submucosal Dissection Evaluation of a New Water Jet System |
https://ClinicalTrials.gov/show/NCT01910974 |
Completed |
Hôpital Edouard Herriot |
2014-02-28 |
| NCT00734890 |
Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00734890 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-06-30 |
| NCT00654160 |
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00654160 |
Completed |
Mayo Clinic |
2010-11-30 |
| NCT00646139 |
KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment |
https://ClinicalTrials.gov/show/NCT00646139 |
Completed |
Roswell Park Cancer Institute |
2008-08-31 |
| NCT00589563 |
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer |
https://ClinicalTrials.gov/show/NCT00589563 |
Completed |
City of Hope Medical Center |
2012-02-29 |
| NCT00569309 |
Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma |
https://ClinicalTrials.gov/show/NCT00569309 |
Completed |
Ohio State University Comprehensive Cancer Center |
2011-07-29 |
| NCT00562380 |
AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma |
https://ClinicalTrials.gov/show/NCT00562380 |
Completed |
National Cancer Institute (NCI) |
2010-04-30 |
| NCT00561418 |
Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma |
https://ClinicalTrials.gov/show/NCT00561418 |
Completed |
Ohio State University Comprehensive Cancer Center |
2012-11-30 |
| NCT00544193 |
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00544193 |
Completed |
City of Hope Medical Center |
2012-08-31 |
| NCT00474994 |
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas |
https://ClinicalTrials.gov/show/NCT00474994 |
Completed |
Memorial Sloan Kettering Cancer Center |
2010-11-30 |
| NCT00454363 |
Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer |
https://ClinicalTrials.gov/show/NCT00454363 |
Completed |
National Cancer Institute (NCI) |
2014-03-31 |
| NCT00445965 |
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer |
https://ClinicalTrials.gov/show/NCT00445965 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2021-01-31 |
| NCT00433550 |
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer |
https://ClinicalTrials.gov/show/NCT00433550 |
Completed |
Alliance for Clinical Trials in Oncology |
2014-12-31 |
| NCT00416351 |
Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin’s Lymphoma That Has Relapsed or Not Responded to Previous Treatment |
https://ClinicalTrials.gov/show/NCT00416351 |
Active, not recruiting |
Memorial Sloan Kettering Cancer Center |
2020-07-31 |
| NCT00397384 |
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00397384 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00088868 |
17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma |
https://ClinicalTrials.gov/show/NCT00088868 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-03-31 |
| NCT00004258 |
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00004258 |
Completed |
Indiana University |
2001-08-31 |
| NCT00003939 |
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00003939 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2000-11-30 |
| NCT00006039 |
Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00006039 |
Completed |
Memorial Sloan Kettering Cancer Center |
2001-03-31 |
| NCT00005021 |
Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma |
https://ClinicalTrials.gov/show/NCT00005021 |
Completed |
Fox Chase Cancer Center |
2003-05-31 |
| NCT00003427 |
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00003427 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-04-30 |
| NCT00006357 |
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00006357 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-04-30 |
| NCT00019344 |
Flavopiridol in Treating Patients With Refractory Cancer |
https://ClinicalTrials.gov/show/NCT00019344 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019474 |
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer |
https://ClinicalTrials.gov/show/NCT00019474 |
Completed |
Montefiore Medical Center |
2000-08-31 |
| NCT00005874 |
Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas |
https://ClinicalTrials.gov/show/NCT00005874 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00004002 |
PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00004002 |
Completed |
NYU Langone Health |
2001-10-31 |
| NCT00002759 |
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00002759 |
Completed |
National Cancer Institute (NCI) |
2002-04-30 |
| NCT00006348 |
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment |
https://ClinicalTrials.gov/show/NCT00006348 |
Completed |
Alliance for Clinical Trials in Oncology |
2001-09-30 |
| NCT00003368 |
Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis |
https://ClinicalTrials.gov/show/NCT00003368 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00079261 |
Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Gemcitabine in Treating Patients With Previously Untreated Aggressive Non-Hodgkin’s Lymphoma |
https://ClinicalTrials.gov/show/NCT00079261 |
Completed |
European Organisation for Research and Treatment of Cancer - EORTC |
2007-03-31 |
| NCT00004904 |
Stem Cell Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00004904 |
Completed |
Northwestern University |
2000-07-31 |
| NCT00003600 |
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy |
https://ClinicalTrials.gov/show/NCT00003600 |
Completed |
Alliance for Clinical Trials in Oncology |
2001-12-31 |
| NCT00016172 |
ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00016172 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-04-30 |
| NCT00005634 |
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy |
https://ClinicalTrials.gov/show/NCT00005634 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-10-31 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00006009 |
Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma |
https://ClinicalTrials.gov/show/NCT00006009 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005804 |
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00005804 |
Completed |
Fred Hutchinson Cancer Research Center |
2002-08-31 |
| NCT00042900 |
Pyroxamide in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00042900 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-09-30 |
| NCT00004911 |
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction |
https://ClinicalTrials.gov/show/NCT00004911 |
Completed |
Northwestern University |
2003-02-28 |
| NCT00004910 |
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction |
https://ClinicalTrials.gov/show/NCT00004910 |
Completed |
Northwestern University |
2003-02-28 |
| NCT00004895 |
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery |
https://ClinicalTrials.gov/show/NCT00004895 |
Completed |
Northwestern University |
2002-10-31 |
| NCT00049712 |
Monoclonal Antibody Therapy in Treating Patients With Refractory Advanced Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00049712 |
Completed |
University of Wisconsin, Madison |
2006-02-28 |
| NCT00049699 |
VNP40101M in Treating Patients With Advanced or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00049699 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00049400 |
S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction |
https://ClinicalTrials.gov/show/NCT00049400 |
Completed |
Southwest Oncology Group |
2006-09-30 |
| NCT00036790 |
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00036790 |
Completed |
University of Wisconsin, Madison |
2005-10-31 |
| NCT00031941 |
CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy |
https://ClinicalTrials.gov/show/NCT00031941 |
Completed |
National Institutes of Health Clinical Center (CC) |
2007-09-30 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00025441 |
Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors |
https://ClinicalTrials.gov/show/NCT00025441 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00025129 |
VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00025129 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019773 |
Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer |
https://ClinicalTrials.gov/show/NCT00019773 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00019513 |
Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas |
https://ClinicalTrials.gov/show/NCT00019513 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00019019 |
Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas |
https://ClinicalTrials.gov/show/NCT00019019 |
Completed |
National Institutes of Health Clinical Center (CC) |
2006-07-31 |
| NCT00006379 |
Non-Ablative Allo HSCT For Hematologic Malignancies or SAA |
https://ClinicalTrials.gov/show/NCT00006379 |
Completed |
Case Comprehensive Cancer Center |
2004-01-31 |
| NCT00006340 |
Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus |
https://ClinicalTrials.gov/show/NCT00006340 |
Completed |
Boston Medical Center |
2000-07-31 |
| NCT00006221 |
BMS-247550 in Treating Patients With Advanced Cancers |
https://ClinicalTrials.gov/show/NCT00006221 |
Completed |
National Cancer Institute (NCI) |
2005-06-30 |
| NCT00005639 |
Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment |
https://ClinicalTrials.gov/show/NCT00005639 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-07-31 |
| NCT00005590 |
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00005590 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00005049 |
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00005049 |
Completed |
NYU Langone Health |
2006-11-30 |
| NCT00004189 |
Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00004189 |
Completed |
National Cancer Institute (NCI) |
2003-07-31 |
| NCT00004066 |
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma |
https://ClinicalTrials.gov/show/NCT00004066 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-10-31 |
| NCT00003993 |
Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma |
https://ClinicalTrials.gov/show/NCT00003993 |
Completed |
National Cancer Institute (NCI) |
2008-07-31 |
| NCT00003687 |
Treatment for Chronic Pain in Patients With Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00003687 |
Completed |
Canadian Cancer Trials Group |
2001-09-26 |